TLR4 and metabolic dysfunction-associated steatotic liver disease: To further investigate the role of LPS-TLR4 signaling in regulating the effect of Sin A on metabolic physiology in NAFLD, we exposed mice to HFD and treated them with the TLR4 inhibitor, CLI-095.